AquaBounty Technologies, Inc. (AQB) ist ein börsennotiertes Unternehmen im Defensiver Konsum Sektor, tätig in der Agricultural Farm Products Branche. Der Hauptsitz des Unternehmens ist in Maynard, MA, United States. Der aktuelle CEO ist David A. Frank.
AQB hat IPO-Datum 2017-01-11, 4 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke, eine Marktkapitalisierung von $4.34M.
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
